
Highlights
The global Flow Cytometry Solutions market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Flow Cytometry Solutions is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Flow Cytometry Solutions is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Flow Cytometry Solutions in Biological Industry is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Flow Cytometry Solutions include BioSure, Analis, Thermo Fisher Scientific Inc., Analog Devices, Inc., PerkinElmer Inc., Agilent, Sartorius AG, Miltenyi Biotec and Labcorp, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Flow Cytometry Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flow Cytometry Solutions.
The Flow Cytometry Solutions market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Flow Cytometry Solutions market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flow Cytometry Solutions companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
BioSure
Analis
Thermo Fisher Scientific Inc.
Analog Devices, Inc.
PerkinElmer Inc.
Agilent
Sartorius AG
Miltenyi Biotec
Labcorp
Sysmex Europe SE
Curiox BioSystems
Bioanalytical Instruments
R&D Systems
MKS Instruments
CytoBuoy bv
Flowcytometry Solutions Pvt. Ltd
Segment by Type
Flow Cytometry Staining Protocol
Propidium Iodide Flow Cytometry Protocol
Others
Segment by Application
Biological Industry
Chemical Industry
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Flow Cytometry Solutions companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Flow Cytometry Solutions Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Flow Cytometry Staining Protocol
1.2.3 Propidium Iodide Flow Cytometry Protocol
1.2.4 Others
1.3 Market by Application
1.3.1 Global Flow Cytometry Solutions Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Biological Industry
1.3.3 Chemical Industry
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Flow Cytometry Solutions Market Perspective (2018-2029)
2.2 Flow Cytometry Solutions Growth Trends by Region
2.2.1 Global Flow Cytometry Solutions Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Flow Cytometry Solutions Historic Market Size by Region (2018-2023)
2.2.3 Flow Cytometry Solutions Forecasted Market Size by Region (2024-2029)
2.3 Flow Cytometry Solutions Market Dynamics
2.3.1 Flow Cytometry Solutions Industry Trends
2.3.2 Flow Cytometry Solutions Market Drivers
2.3.3 Flow Cytometry Solutions Market Challenges
2.3.4 Flow Cytometry Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Flow Cytometry Solutions Players by Revenue
3.1.1 Global Top Flow Cytometry Solutions Players by Revenue (2018-2023)
3.1.2 Global Flow Cytometry Solutions Revenue Market Share by Players (2018-2023)
3.2 Global Flow Cytometry Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Flow Cytometry Solutions Revenue
3.4 Global Flow Cytometry Solutions Market Concentration Ratio
3.4.1 Global Flow Cytometry Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Flow Cytometry Solutions Revenue in 2022
3.5 Flow Cytometry Solutions Key Players Head office and Area Served
3.6 Key Players Flow Cytometry Solutions Product Solution and Service
3.7 Date of Enter into Flow Cytometry Solutions Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Flow Cytometry Solutions Breakdown Data by Type
4.1 Global Flow Cytometry Solutions Historic Market Size by Type (2018-2023)
4.2 Global Flow Cytometry Solutions Forecasted Market Size by Type (2024-2029)
5 Flow Cytometry Solutions Breakdown Data by Application
5.1 Global Flow Cytometry Solutions Historic Market Size by Application (2018-2023)
5.2 Global Flow Cytometry Solutions Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Flow Cytometry Solutions Market Size (2018-2029)
6.2 North America Flow Cytometry Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Flow Cytometry Solutions Market Size by Country (2018-2023)
6.4 North America Flow Cytometry Solutions Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Flow Cytometry Solutions Market Size (2018-2029)
7.2 Europe Flow Cytometry Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Flow Cytometry Solutions Market Size by Country (2018-2023)
7.4 Europe Flow Cytometry Solutions Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Flow Cytometry Solutions Market Size (2018-2029)
8.2 Asia-Pacific Flow Cytometry Solutions Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Flow Cytometry Solutions Market Size by Region (2018-2023)
8.4 Asia-Pacific Flow Cytometry Solutions Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Flow Cytometry Solutions Market Size (2018-2029)
9.2 Latin America Flow Cytometry Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Flow Cytometry Solutions Market Size by Country (2018-2023)
9.4 Latin America Flow Cytometry Solutions Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Flow Cytometry Solutions Market Size (2018-2029)
10.2 Middle East & Africa Flow Cytometry Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Flow Cytometry Solutions Market Size by Country (2018-2023)
10.4 Middle East & Africa Flow Cytometry Solutions Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioSure
11.1.1 BioSure Company Detail
11.1.2 BioSure Business Overview
11.1.3 BioSure Flow Cytometry Solutions Introduction
11.1.4 BioSure Revenue in Flow Cytometry Solutions Business (2018-2023)
11.1.5 BioSure Recent Development
11.2 Analis
11.2.1 Analis Company Detail
11.2.2 Analis Business Overview
11.2.3 Analis Flow Cytometry Solutions Introduction
11.2.4 Analis Revenue in Flow Cytometry Solutions Business (2018-2023)
11.2.5 Analis Recent Development
11.3 Thermo Fisher Scientific Inc.
11.3.1 Thermo Fisher Scientific Inc. Company Detail
11.3.2 Thermo Fisher Scientific Inc. Business Overview
11.3.3 Thermo Fisher Scientific Inc. Flow Cytometry Solutions Introduction
11.3.4 Thermo Fisher Scientific Inc. Revenue in Flow Cytometry Solutions Business (2018-2023)
11.3.5 Thermo Fisher Scientific Inc. Recent Development
11.4 Analog Devices, Inc.
11.4.1 Analog Devices, Inc. Company Detail
11.4.2 Analog Devices, Inc. Business Overview
11.4.3 Analog Devices, Inc. Flow Cytometry Solutions Introduction
11.4.4 Analog Devices, Inc. Revenue in Flow Cytometry Solutions Business (2018-2023)
11.4.5 Analog Devices, Inc. Recent Development
11.5 PerkinElmer Inc.
11.5.1 PerkinElmer Inc. Company Detail
11.5.2 PerkinElmer Inc. Business Overview
11.5.3 PerkinElmer Inc. Flow Cytometry Solutions Introduction
11.5.4 PerkinElmer Inc. Revenue in Flow Cytometry Solutions Business (2018-2023)
11.5.5 PerkinElmer Inc. Recent Development
11.6 Agilent
11.6.1 Agilent Company Detail
11.6.2 Agilent Business Overview
11.6.3 Agilent Flow Cytometry Solutions Introduction
11.6.4 Agilent Revenue in Flow Cytometry Solutions Business (2018-2023)
11.6.5 Agilent Recent Development
11.7 Sartorius AG
11.7.1 Sartorius AG Company Detail
11.7.2 Sartorius AG Business Overview
11.7.3 Sartorius AG Flow Cytometry Solutions Introduction
11.7.4 Sartorius AG Revenue in Flow Cytometry Solutions Business (2018-2023)
11.7.5 Sartorius AG Recent Development
11.8 Miltenyi Biotec
11.8.1 Miltenyi Biotec Company Detail
11.8.2 Miltenyi Biotec Business Overview
11.8.3 Miltenyi Biotec Flow Cytometry Solutions Introduction
11.8.4 Miltenyi Biotec Revenue in Flow Cytometry Solutions Business (2018-2023)
11.8.5 Miltenyi Biotec Recent Development
11.9 Labcorp
11.9.1 Labcorp Company Detail
11.9.2 Labcorp Business Overview
11.9.3 Labcorp Flow Cytometry Solutions Introduction
11.9.4 Labcorp Revenue in Flow Cytometry Solutions Business (2018-2023)
11.9.5 Labcorp Recent Development
11.10 Sysmex Europe SE
11.10.1 Sysmex Europe SE Company Detail
11.10.2 Sysmex Europe SE Business Overview
11.10.3 Sysmex Europe SE Flow Cytometry Solutions Introduction
11.10.4 Sysmex Europe SE Revenue in Flow Cytometry Solutions Business (2018-2023)
11.10.5 Sysmex Europe SE Recent Development
11.11 Curiox BioSystems
11.11.1 Curiox BioSystems Company Detail
11.11.2 Curiox BioSystems Business Overview
11.11.3 Curiox BioSystems Flow Cytometry Solutions Introduction
11.11.4 Curiox BioSystems Revenue in Flow Cytometry Solutions Business (2018-2023)
11.11.5 Curiox BioSystems Recent Development
11.12 Bioanalytical Instruments
11.12.1 Bioanalytical Instruments Company Detail
11.12.2 Bioanalytical Instruments Business Overview
11.12.3 Bioanalytical Instruments Flow Cytometry Solutions Introduction
11.12.4 Bioanalytical Instruments Revenue in Flow Cytometry Solutions Business (2018-2023)
11.12.5 Bioanalytical Instruments Recent Development
11.13 R&D Systems
11.13.1 R&D Systems Company Detail
11.13.2 R&D Systems Business Overview
11.13.3 R&D Systems Flow Cytometry Solutions Introduction
11.13.4 R&D Systems Revenue in Flow Cytometry Solutions Business (2018-2023)
11.13.5 R&D Systems Recent Development
11.14 MKS Instruments
11.14.1 MKS Instruments Company Detail
11.14.2 MKS Instruments Business Overview
11.14.3 MKS Instruments Flow Cytometry Solutions Introduction
11.14.4 MKS Instruments Revenue in Flow Cytometry Solutions Business (2018-2023)
11.14.5 MKS Instruments Recent Development
11.15 CytoBuoy bv
11.15.1 CytoBuoy bv Company Detail
11.15.2 CytoBuoy bv Business Overview
11.15.3 CytoBuoy bv Flow Cytometry Solutions Introduction
11.15.4 CytoBuoy bv Revenue in Flow Cytometry Solutions Business (2018-2023)
11.15.5 CytoBuoy bv Recent Development
11.16 Flowcytometry Solutions Pvt. Ltd
11.16.1 Flowcytometry Solutions Pvt. Ltd Company Detail
11.16.2 Flowcytometry Solutions Pvt. Ltd Business Overview
11.16.3 Flowcytometry Solutions Pvt. Ltd Flow Cytometry Solutions Introduction
11.16.4 Flowcytometry Solutions Pvt. Ltd Revenue in Flow Cytometry Solutions Business (2018-2023)
11.16.5 Flowcytometry Solutions Pvt. Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
BioSure
Analis
Thermo Fisher Scientific Inc.
Analog Devices, Inc.
PerkinElmer Inc.
Agilent
Sartorius AG
Miltenyi Biotec
Labcorp
Sysmex Europe SE
Curiox BioSystems
Bioanalytical Instruments
R&D Systems
MKS Instruments
CytoBuoy bv
Flowcytometry Solutions Pvt. Ltd
Ìý
Ìý
*If Applicable.
